Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Current Computer-Aided Drug Design|October 19, 2023
Exploring the Molecular Mechanism of Niuxi-Mugua Formula in Treating Coronavirus Disease 2019 <i>via</i> Network Pharmacology, Computational Biology, and Surface Plasmon Resonance VerificationWei Wang, Xu Cao, Yi-Nan Cao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 16, 2016
Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic MiceYi Zhang, Hong An, Si-Yuan Pan, et al.
World Journal of Hepatology|April 3, 2025
Immune cells in metabolic associated fatty liver disease: Global trends and hotspots (2004-2024)Wen-Ying Qi, Shi-Hao Zheng, Si-Ze Li, et al.
Acta Pharmacologica Sinica|August 8, 2025
Galangin, a novel Kv7 potassium channel opener, exerts potent antinociceptive effects in multiple chronic pain mouse modelsBo Yang, Hui Liu, Wen-Jing Zhao, et al.
Chinese Journal of Integrative Medicine|December 10, 2016
Effect of Shuanghu Qinggan Granule () and Yigan Yiqi Jieyu Granule () plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trialYong-An Ye, De-Lu Tian, Jian Jiang, et al.
Chinese Journal of Integrative Medicine|September 14, 2018
Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled TrialYong-An Ye, Xiao-Ke Li, Da-Qiao Zhou, et al.
Chinese Journal of Integrative Medicine|January 11, 2020
Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week TrialXiao-Ke Li, Ming-Xiang Zhang, Feng-Zhen Shao, et al.
Pageof 2